Procter & Gamble, the Consumer Defensive sector company, was revisited by a Wall Street analyst today. Analyst Robert Moskow from TD Cowen maintained a Buy rating on the stock and has a $168.00 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Robert Moskow has given his Buy rating due to a combination of factors that suggest potential for Procter & Gamble’s medium-term growth despite current challenges. The company reported a slightly better-than-expected first quarter with organic growth and an increase in EPS, although it continues to face share losses in key categories. Moskow believes that P&G’s strong innovation pipeline and cost savings from restructuring will provide the necessary reinvestment fuel to regain competitiveness.
Additionally, the upcoming change in CEO is seen as a catalyst for reinvigoration. While the fiscal year 2026 outlook remains broad and unchanged, reflecting the company’s reinvestment needs, Moskow anticipates sequential improvement in EPS growth in the second half of the year. This expectation is based on the timing of cost savings, new product innovations, and easier comparisons from the previous year. Despite the challenges in North America and Europe, growth in the Chinese market offers a positive outlook, contributing to the Buy rating.
Moskow covers the Consumer Defensive sector, focusing on stocks such as Clorox, McCormick & Company, and PepsiCo. According to TipRanks, Moskow has an average return of 3.2% and a 46.44% success rate on recommended stocks.
In another report released yesterday, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $171.00 price target.